Interesting thoughts on the use of ACE inhibitors and ARBs, alongside considerations regarding asprin.   We look at the following papers:   Anesthesia and Analgesia: A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.   https://www.ncbi.nlm.nih.gov/pubmed/29381513   Anesthesia and Analgesia: A Prospective International Multicentre Cohort Study of Intraoperative Heart Rate and Systolic Blood Pressure and Myocardial Injury After Noncardiac Surgery: Results of the VISION Study

https://journals.lww.com/anesthesia-analgesia/FullText/2018/06000/A_Prospective_International_Multicentre_Cohort.25.aspx

Gynecologic Oncology: Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.

https://www.ncbi.nlm.nih.gov/pubmed/30249529

JAMA Surgery: Association of Aspirin With Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Compared With Other Anticoagulants: A Noninferiority Analysis.

https://www.ncbi.nlm.nih.gov/pubmed/30347089

Presented by Desiree Chappell with Monty Mythen and their guests Barbara Slawski, Professor of Medicine and Orthopaedic Surgery; Chief, Section of Perioperative and Consultative Medicine; Froedtert and Medical College of Wisconsin and Steven L. Cohn, Professor Emeritus, Director – Medical Consultation Service, Jackson Memorial Hospital University of Miami Miller School of Medicine.

--

Do you have your ticket to the Dallas Master's Course being organised in March by EBPOM USA yet?

Find out more here: https://www.ebpom.org/EBPOM-USA-2019

As a TopMedTalk subscriber you can get a 20% discount for 1 person, or a 50% discount for a team. Just use the promo code "DAL 20" if you're solo or "EDAL 50" if you're coming as a group.